A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
Interventions: DRUG: Giredestrant|DRUG: Abemaciclib|DRUG: Ipatasertib|DRUG: Inavolisib|DRUG: Ribociclib|DRUG: Everolimus|DRUG: Samuraciclib|DRUG: PH FDC SC|DRUG: Palbociclib|DRUG: Atezolizumab
Sponsor: Hoffmann-La Roche